| Literature DB >> 11897024 |
Lakshminarayan M Iyer1, Eugene V Koonin, L Aravind.
Abstract
BACKGROUND: Viral DNA-binding proteins have served as good models to study the biochemistry of transcription regulation and chromatin dynamics. Computational analysis of viral DNA-binding regulatory proteins and identification of their previously undetected homologs encoded by cellular genomes might lead to a better understanding of their function and evolution in both viral and cellular systems.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11897024 PMCID: PMC88810 DOI: 10.1186/gb-2002-3-3-research0012
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Distribution of KilA-N, Bro-N and associated conserved domains in viral and cellular proteomes
| Organism | Host, if phage or virus | Domain architectures |
| NCLDVs, baculoviruses | Eukaryotes | KilA-N solo (AMV, FPV) |
| KilA-N + Bro-C (AMV, CIV, FPV) | ||
| KilA-N + T5ORF172 (CIV) | ||
| KilA-N + RING finger (chordopoxviruses); ectromelia p28 [12] | ||
| KilA-N + CCCH + RING finger (FPV) | ||
| Bro-N solo (MSV, AMV, HzNV, LdNV, XnGV) | ||
| Bro-N + Bro-N (CnBV, CpGV, PxGV) | ||
| Bro-N + T5ORF172 (CIV, MSV, ESV, baculoviruses) | ||
| Bro-N + Bro-C (AMV, baculoviruses); BroA, BroD of BmNV [10] | ||
| Bro-N + Bro-N + Bro-C (HaNV) | ||
| Bro-N + VSR nuclease (MSV, CIV) | ||
| Bro-N + Bro-N (CnBV, CpGV) | ||
| Bro-N + Bro-C (AMV, baculoviruses) | ||
| MSV199 solo (MSV) | ||
| MSV199 + T5ORF172 (AMV, MSV, CIV) | ||
| MSV199 + UVRC (CIV) | ||
| MSV199 + Bro-C (CIV) | ||
| Bro-C solo (CIV, DpAV4, AcNV, BmNV, EpNV, LdNV, LsNV, MbNV, OpNV) | ||
| T5ORF172 solo (CIV, LdNV) | ||
| Proteobacteria | - | KilA-N solo ( |
| Bro-N solo ( | ||
| Bro-N (2/3 copies) + XF1559 ( | ||
| XF0704 + Bro-N ( | ||
| Bro-N + P22AR-C ( | ||
| KilA-C solo ( | ||
| φ31-ORF238N + P22AR-C ( | ||
| φ31-ORF238N + wHTH ( | ||
| XF0704 solo ( | ||
| XF1559 solo ( | ||
| RHA solo ( | ||
| RHA + D3ORF11-C ( | ||
| RHA + ASH ( | ||
| D3ORF11-C + P22AR-N ( | ||
| bIL285ORF6-N solo ( | ||
| ASH solo ( | ||
| T5ORF172 solo ( | ||
| Low-GC Gram-positive bacteria/ Firmicutes | - | Bro-N solo ( |
| Bro-N + HTH ( | ||
| Bro-N + KilA-C ( | ||
| RHA solo ( | ||
| φ31-ORF238N + KilA-C ( | ||
| φ31-ORF238N + φSLT-orf81a ( | ||
| T5ORF172 solo ( | ||
| KilA-C solo ( | ||
| High-GC Gram-positive bacteria | - | Bro-N solo ( |
| Phages BP7888, BP933W, BPHK97, BPN15, BPHK620, BPHK022, BPφ-R73 BPP22, BPH-19B, BPP1, BPP4, BPP27, BPφ80, BPT5, BPVT2-Sa | Bro-N solo (BPN15) | |
| KilA-N + KilA-C; phage P1 - KilA [14] | ||
| KilA-N + D3ORF11-C (BPHK620) | ||
| KilA-N + p63C (BP933W, BPHK97) | ||
| RHA solo (BPφ80); BPP22 ORF 201 [47] | ||
| RHA + KilA-C (BPHK022, BP933W, BPP1, BPH-19B, BPHK97, BPHK620, | ||
| BPVT2-Sa); Reduced on IHF- (ROI) [48] | ||
| KilA-C solo; bacteriophage P1 antirepressor Ant1/Ant2 [49] | ||
| φ31-ORF238N + P22AR-C (BP933W, BPVT2-Sa) | ||
| D3ORF11-C + P22AR-N (BP933W, BP7888) | ||
| ASH solo (BPP4, BPφ-R73, BPN15) | ||
| bIL285ORF6-N + P22AR-C (BPVT2-Sa) | ||
| T5ORF172 solo (BPT5, BPP27) | ||
| Phage P22 | P22AR-N + Bro-N + P22AR-C; BPP22 antirepressor [33,34] | |
| RHA + D3ORF11-C [46] | ||
| Phage APSE-1 | RHA (solo) | |
| Bro-N (solo) | ||
| Phage D3 | KilA-N + D3ORF11-C | |
| BPφPV83, BPφETA, BPφSLT | Bro-N + KilA-C (BPφPV83) | |
| φ31-ORF238N + KilA-C (BPφETA) | ||
| φSLT-ORF81a solo (BPφSLT) | ||
| RHA solo (BPφSLT) | ||
| BPbIL285, BPbIL286, BPbIL311, BPbIL309, BPpi3, BPφ31.1, BPTP901-1, BPR1T, BPBK5-T, BPLL-H, BPTuc2009 | Bro-N + KilA-C (BPR1T, BPBK5-T, BPLL-H, BPbIL309) | |
| KilA-C solo (BPR1T) | ||
| RHA solo (BpbIL310, BPbIL311) | ||
| φ31-ORF238N + bIL285ORF6-C (BPpi3, BPTuc2009, BPbIL286, BPφ31.1) | ||
| bIL285ORF6-N + bIL285ORF6-C (BPbIL285, BPTP901-1) | ||
| LcBPA2 | Bro-N solo | |
| BPTP-J34, BPSfi21 | φ31-ORF238N + KilA-C | |
| BPA118 | φ31-ORF238N + KilA-C | |
| BPSpβc2 | RHA + KilA-C | |
| BPMx8 (Myxococcal phage) | Bro-N + p63C |
Figure 1Sequence and structural analysis of the KilA-N domain. (a) Multiple alignment of KilA-N and APSES domains. Sequences are designated by their gene name, followed by species abbreviation and the Genbank index (gi) number. Species abbreviations are listed in Materials and methods. The coloring reflects the conservation profile at 80% consensus of amino acids. h, hydrophobic residues (L,I,Y,F,M,W,A,C,V in the single-letter amino-acid code); a,aromatic residues (F,H,Y,W); and l, aliphatic residues (L,I,A,V), all shaded yellow. c, charged residues (K,E,R,D,H); +, basic residues (K,R,H); -, acidic residues (D,E); and p, polar residues (S,T,E,D,R,K,H,N,Q), all colored magenta. s, small residues (S,A,C,G,D,N,P,V,T) colored green. b, big residues (L,I,F,M,W,Y,E,R,K,Q) shaded gray. Further grouping of sequences is based on the association of KilA-Nwith other domains as follows: 1, fused to KilA-C; 2, fused to D3ORF11-C; 3, fused to Mx8p63C; 4, fused to T5ORF172; 5, fused to Bro-C; 6, fused to a CCCH domain and a RING finger; 7, fused to a ring finger. (b) Structural comparison of the APSES, LAGLIDADG and tRNA splicing endonuclease (TEN) domains. The ribbon diagrams were drawn using Molscript.
Figure 2Domain architectures and architecture graphs of the KilA-N, Bro-N and other associated domains. (a) Domain architectures of the KilA-N, Bro-N and other associated domains. Gene names and species abbreviations are given below the architectures. Species abbreviations are listed in Materials and methods. (b) Domain architecture graph for the KilA-N, Bro-N and other associated domains. Each vertex represents a domain, and edges indicate domain combinations. Arrows point from the amino terminus to the carboxyl terminus of a multidomain protein. Architectures involving more than two colinear domains (see the three-domain proteins in (a)) are connected by red lines. Circular arrows indicate multiple copies of the same domain.
Domains identified in this study
| Domain name | Domain definition |
| Bro-N | Amino-terminal domain of baculovirus BRO proteins |
| KilA-N | Amino-terminal domain of phage P1 KilA |
| Bro-C | Carboxy-terminal domain of BmNV BroA and BroD |
| KilA-C | Carboxy-terminal domain of phage P1 KilA |
| T5ORF172 | Domain present in ORF172 product of bacteriophage T5 |
| P22AR-N | Amino-terminal domain of the phage P22 antirepressor |
| P22AR-C | Carboxy-terminal domain of the phage P22 antirepressor |
| Mx8P63C | Carboxy-terminal domain of the |
| XF1559 | Carboxy-terminal domain of the XF1559 protein of |
| XF0704 | Carboxy-terminal domain of the XF0704 protein of |
| D3ORF11-C | Carboxy-terminal domain of ORF11 product of |
| RHA | Domain present in the RHA protein of bacteriophage φ81 |
| MSV199 | Domain present in MSV199 of |
| bIL285ORF6-N | Amino-terminal domain of bacteriophage bIL2850 ORF6 |
| bIL285ORF6-C | Carboxy-terminal domain of bacteriophage bIL2850 ORF6 |
| P4ASH | Domain present in the ASH protein of bacteriophage P4 |
| φ31ORF238-N | Amino-terminal domain of bacteriophage φ31.1 ORF238 |
| ORF81a | Domain present in ORF81a of the temperate phage φSLT of |
Figure 3Multiple alignment of Bro-N domains. The color scheme is as in Figure 1. The coloring reflects the conservation profile of amino acid residues at 85% consensus. Further groupings described reflect domain architectures as follows: 1, fused to KilA-C; 2, fused to Mx8P63C; 3, fused to P22AR-C; 4, Xylella fastidiosa specific Bro-N duplications and fusions; 5, fused to T5ORF172; 6, fused to Bro-C; 7, duplicated Bro-N fused to Bro-C; 8, fused to a VSR nuclease; 9, duplicated Bro-N; 10, fused to a HTH. Species abbreviations are listed in Materials and methods.